The outcome of hyperacute grade 3-4 steroid-refractory graft-versus-host-disease (SR-GVHD) following haploidentical HSCT is dismal.
The replacement of ATG with Abatacept seemed to produce encouraging early response and might warrant further investigation.
Sirolimus in combination with Abatacept might improve recovery of T regulatory cells and result in sustained response.